PHARMAC is seeking feedback on a proposal to list nicardipine hydrochloride injection 2.5 mg/mL, 10 mL vial in Part II of Section H of the Pharmaceutical Schedule from 1 June 2015.

In summary, this proposal would result in nicardipine hydrochloride injection being listed for paediatric patients subject to restriction criteria.

For more details, go to: http://www.pharmac.health.nz/news/consultation-2015-04-01-nicardipine/